Cancer drugs covered by WPA

Phone Us


Targeted/Biological therapies, when used for their European Medicines Agency (EMA) therapeutic indication, are covered by WPA, when these are not readily available to you as an NHS patient

In the past, any medication used to treat cancer was regarded as chemotherapy. However, over the last 20 years, new types of medication that work in a different way to chemotherapy have been introduced.

These new types of medication are known as Targeted/Biological therapies. This is because they are designed to target and disrupt one or more of the biological processes that cancerous cells use to grow and reproduce. In contrast, chemotherapy medications are designed to have a poisonous effect on cancerous cells.

Targeted/Biological therapies, when used for their European Medicines Agency (EMA) therapeutic indication, are covered by WPA, when these are not readily available to you as an NHS patient (but some group schemes may vary).

If you visit your Cancer Specialist and are prescribed one of these Targeted drugs, your Oncologist will be able to advise you of their availability on the NHS or the Cancer Drugs Fund (England). You can check whether your drug treatment is licensed for your cancer on www.ema.europa.eu and/or the NHS status of your drug on www.nice.org.uk, www.england.nhs.uk or www.scottishmedicines.org.uk - however we will be happy to advise you on your specific case.

We have provided a list of brand and generic names of commonly used Targeted/Biological therapies below; however, if you are not sure whether your treatment includes a Targeted/Biological therapy please contact WPA.

If you have any questions regarding the provision of benefit for any aspects of your treatment, please contact WPA to discuss the cover that can be provided prior to any treatment commencing.

Please click here for WPA´s current oncology schedule.


Last updated: 01/02/2017


Brand name Generic name   Brand name Generic name
Adcetris Brentuximab Vedotin   Afinitor Everolimus
Arzerra Ofatumumab   Avastin Bevacizumab
Bexxar Iodine 133-Tositumomab   Bosulif Bosutinib
Cabozantinib Cabometyx   Caprelsa Vandetanib
Cimzia Certolizumab   Cyramza Ramucirumab
Darzalex Daratumumab   Entyvio Vedolizumab
Erbitux Cetuximab   Eylea Aflibercept
Gazyvaro Obinutuzumab   Giotrif Afatinib
Glivec Imatinib   Herceptin Trastuzumab
Humira Adalimumab   Ibrance Palbociclib
Imbruvica Ibrutinib   Imlygic Talimogene Laherparepvec
Imnovid Pomalidomide   Inylta Axitinib
Kadcyla Trastuzumab Emtansine   Keytruda Pembrolizumab
Kyprolis Carfilzomib   Lartruvo Olaratumab
Lenvima/Kisplyx Lenvatinib   Lucentis Ranibizumab
Lynparza Olaparib   MabCampath Alemtuzumab
Mabthera Rituximab   Macugen Pegaptanib
Mekinist Trametinib   Mylotarg Gemtuzumab
Nexavar Sorafenib   Ninlaro Ixazomib
Opdivo Nivolumab   Perjeta Pertuzumab
Pomalyst Pomalidomide   Prolia Denosumab
Raptiva Efalizumab   Remicade Infliximab
Revlimid Lenalidomide   RoActemra Tocilizumab
Soliris Eculizumab   Sprycel Dasatinib
Stivarga Regorafenib   Sutent Sunitinib
Tafinlar Dabrafenib   Tagrisso Osimertinib
Tarceva Erlotinib   Tasigna Nilotinib
Tyverb Lapatanib   Vargatef Nintedanib
Vectibix Panitumumab   Velcade Bortezomib
Votrient Pazopanib   Votubia Everolimus
Yervoy Ipilimumab   Xalkori Crizotinib
Xgeva Denosumab   Xtandi Enzalutamide
Zaltrap Aflibercept   Zelboraf Vemurafenib
Zevalin Ibritumomab   Zytiga Abiraterone


Please click here to view useful medical website links.